Pharma fallout from Iran war won't end with ceasefire
Pharma fallout from Iran war won't end with ceasefire
The Iran war is highlighting the fragile nature of global drug supply chains as disruptions ripple far beyond the Persian Gulf.
Why it matters: Even if the ceasefire holds, disruptions to air cargo and the Strait of Hormuz bring the threat of higher prices for generic drugs and spot shortages, especially in developing countries.
The conflict is also disrupting clinical trials of experimental cancer, heart and other treatments in countries like Turkey, Israel and Egypt, according to data science company Phesi.
State of play: 10-20% of global pharmaceutical commerce passes through the Middle East, according to Prashant Yadav, senior fellow at the Council on Foreign Relations. (AXIOS, USA, 09.04.026)
https://www.axios.com/2026/04/09/iran-war-shock-drug-supply-chain